D. Hayes et al., SODIUM CLODRONATE IN A PATIENT WITH THE EISENMENGER SYNDROME, HYPERPARATHYROIDISM AND MULTIPLE ENDOCRINE ADENOMATOSIS, Irish medical journal, 86(4), 1993, pp. 133-133
The use of sodium clodronate in the treatment of primary hyperparathyr
oidism is described. The drug successfully reduced the serium calcium
but without improvement in the patients muscule and joint syptoms. It
appears that mild degrees of hypercaclaemia have few clinical effects.